The present invention relates to a method for producing a powder-type hemostatic agent and a powder-type hemostatic agent according thereto, which has excellent biocompatibility by using a natural polymer and provides a high blood absorption rate and blood coagulation ability through a cross-linked ...
In order to enhance the mechanical‐ physical properties and functionality, two types of fillers were loaded: hemostatic agent (kaolin or montmorillonite) ... I Eshkol‐Yogev,T Tobias,A Keren,... - 《Polymers for Advanced Technologies》 被引量: 0发表: 2022年 Hemostatic device comprising an ads...
1.Can also be used in medicine as a hemostatic agent and generation of plasma, can also be used to treat diarrhea and heavy metal poisoning. 2. Used as emulsifier stabilizer and thickener, China can be used for all types of food, according to the production needs of ap...
For industry: Petroleum drilling fluid decreasing and filtering agent; Boiler anti-scaling agent and water quality stabilizer; Cementing agent for pulverized coal shaping; Ceramic pug additive; Ore dressing agent. Storage Sodium Humate can be stored in all types of indoor storage are...
other hemostatic defects (including those secondary to severe hepatic or renal disease), or any condition for which bleeding constitutes a significant hazard or would be particularly difficult to manage because of its location, or who are at high risk for embolic complications (e.g., venous thromb...
Accordingly, these types of formulations can provide the therapeutic benefits of the divalent metal cation, and of the additional therapeutic agent. Preferably the divalent metal cation salt is a calcium salt such as calcium lactate, calcium sulfate, calcium carbonate, calcium citrate and combinations ...
The present invention relates to: a biocompatible powder-type hemostatic agent that is highly absorbent and has bio-tissue adhesion; and a method for producing same. More specifically, the biocompatible powder-type hemostatic agent is characterized by comprising first particles that are highly absorbent...
Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model. Endoscopy. 2011; 43 (4):296–299.Giday SA, Kim Y, Krishnamurty DM, Ducharme R, Liang DB, Shin EJ, et al. Long-term ...
Long‑term randomized controlled trial of a novel nanopowder hemostatic agent (TC‑325) for control of severe arterial upper gastrointestinal bleeding in a porcine model. Endoscopy 2011;43:296‑9.S. A. Giday, Y. Kim, D. M. Krishnamurty et al., "Long-term randomized controlled trial ...
solution of water and alcohol, and calcium is added to produce less than one calcium per two carboxyl functional groups, and then filtering and freeze-drying is performed to stop the blood flow, thereby providing hemostatic agent powder which is not only easy to use but also safe for human ...